The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication In Vitro and Decreases Viral Titers and Disease Progression in Syrian Hamsters
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication
In Vitro
and Decreases Viral Titers and Disease Progression in Syrian Hamsters
Authors
Keywords
-
Journal
mBio
Volume 13, Issue 2, Pages -
Publisher
American Society for Microbiology
Online
2022-03-01
DOI
10.1128/mbio.03705-21
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2
- (2021) Tianling Ou et al. PLoS Pathogens
- Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A
- (2021) Kris M. White et al. SCIENCE
- Epidemiology and outcomes of COVID-19 in HIV-infected individuals: a systematic review and meta-analysis
- (2021) Paddy Ssentongo et al. Scientific Reports
- Can remdesivir and its parent nucleoside GS-441524 be potential oral drugs? An in vitro and in vivo DMPK assessment
- (2021) Jiashu Xie et al. Acta Pharmaceutica Sinica B
- Molnupiravir: coding for catastrophe
- (2021) Brandon Malone et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Rapid, reliable, and reproducible cell fusion assay to quantify SARS-Cov-2 spike interaction with hACE2
- (2021) Min Zhao et al. PLoS Pathogens
- Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients
- (2021) Angélica Jayk Bernal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients
- (2021) Robert L. Gottlieb et al. NEW ENGLAND JOURNAL OF MEDICINE
- An oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19
- (2021) Dafydd R. Owen et al. SCIENCE
- Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19
- (2021) Britton Boras et al. Nature Communications
- SynergyFinder: a web application for analyzing drug combination dose–response matrix data
- (2020) Aleksandr Ianevski et al. BIOINFORMATICS
- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- (2020) Manli Wang et al. CELL RESEARCH
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- What do we know about remdesivir drug interactions?
- (2020) Katherine Yang CTS-Clinical and Translational Science
- Alterations of redox and iron metabolism accompany the development of HIV latency
- (2020) Iart Luca Shytaj et al. EMBO JOURNAL
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
- (2020) Yeming Wang et al. LANCET
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Remdesivir: Review of pharmacology, pre‐clinical data and emerging clinical experience for COVID‐19
- (2020) Sarah CJ Jorgensen et al. PHARMACOTHERAPY
- Rapid repurposing of drugs for COVID-19
- (2020) R. Kiplin Guy et al. SCIENCE
- Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
- (2020) Linlin Zhang et al. SCIENCE
- Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir
- (2020) Wanchao Yin et al. SCIENCE
- Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
- (2020) Xiuyuan Ou et al. Nature Communications
- Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
- (2020) Chunlong Ma et al. CELL RESEARCH
- Drug-induced liver injury in a COVID-19 patient: potential interaction of remdesivir with P-glycoprotein inhibitors
- (2020) Emiel Leegwater et al. CLINICAL INFECTIOUS DISEASES
- Computational discovery of small drug-like compounds as potential inhibitors of SARS-CoV-2 main protease
- (2020) Alexander M. Andrianov et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- In-silico drug repurposing and molecular dynamics puzzled out potential SARS-CoV-2 main protease inhibitors
- (2020) Mahmoud A. A. Ibrahim et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Investigating the binding affinity, interaction, and structure-activity-relationship of 76 prescription antiviral drugs targeting RdRp and Mpro of SARS-CoV-2
- (2020) Sinthyia Ahmed et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Identification of potential drug candidates to combat COVID-19: a structural study using the main protease (mpro) of SARS-CoV-2
- (2020) Pradeep Sharma et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Inhibitors of SARS-CoV-2 Entry: Current and Future Opportunities
- (2020) Siyu Xiu et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
- (2020) David R. Boulware et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development
- (2020) Masaki Imai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Age-Dependent Progression of SARS-CoV-2 Infection in Syrian Hamsters
- (2020) Nikolaus Osterrieder et al. Viruses-Basel
- SARS‐CoV‐2 and HIV coinfection: clinical experience from Rhode Island, United States
- (2020) Katrina M Byrd et al. Journal of the International AIDS Society
- Critical Role of Type III Interferon in Controlling SARS-CoV-2 Infection in Human Intestinal Epithelial Cells
- (2020) Megan L. Stanifer et al. Cell Reports
- Antiviral Activity and Safety of Darunavir/Cobicistat for the Treatment of COVID-19
- (2020) Jun Chen et al. Open Forum Infectious Diseases
- Pharmacokinetics and tissue distribution of remdesivir and its metabolites nucleotide monophosphate, nucleotide triphosphate, and nucleoside in mice
- (2020) Wen-juan Hu et al. ACTA PHARMACOLOGICA SINICA
- Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19
- (2020) Xuping Xie et al. Nature Communications
- SARS-CoV-2 S1 and N-based serological assays reveal rapid seroconversion and induction of specific antibody response in COVID-19 patients
- (2020) Abdullah Algaissi et al. Scientific Reports
- Microscopy‐based assay for semi‐quantitative detection of SARS‐CoV‐2 specific antibodies in human sera
- (2020) Constantin Pape et al. BIOESSAYS
- Integrative Imaging Reveals SARS-CoV-2-Induced Reshaping of Subcellular Morphologies
- (2020) Mirko Cortese et al. Cell Host & Microbe
- Remdesivir and Acute Renal Failure: A Potential Safety Signal From Disproportionality Analysis of the WHO Safety Database
- (2020) Alexandre O. Gérard et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Synergistic and Antagonistic Drug Combinations against SARS-CoV-2
- (2020) Tesia Bobrowski et al. MOLECULAR THERAPY
- SARS-CoV-2 structure and replication characterized by in situ cryo-electron tomography
- (2020) Steffen Klein et al. Nature Communications
- CypReact: A Software Tool for in Silico Reactant Prediction for Human Cytochrome P450 Enzymes
- (2018) Siyang Tian et al. Journal of Chemical Information and Modeling
- Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses
- (2017) Dustin Siegel et al. JOURNAL OF MEDICINAL CHEMISTRY
- DrugBank 5.0: a major update to the DrugBank database for 2018
- (2017) David S Wishart et al. NUCLEIC ACIDS RESEARCH
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
- (2017) Antoine Daina et al. Scientific Reports
- Interaction Entropy: A New Paradigm for Highly Efficient and Reliable Computation of Protein–Ligand Binding Free Energy
- (2016) Lili Duan et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB
- (2015) James A. Maier et al. Journal of Chemical Theory and Computation
- From non-A, non-B hepatitis to hepatitis C virus cure
- (2015) Jean-Michel Pawlotsky et al. JOURNAL OF HEPATOLOGY
- pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures
- (2015) Douglas E. V. Pires et al. JOURNAL OF MEDICINAL CHEMISTRY
- Searching for Drug Synergy in Complex Dose–Response Landscapes Using an Interaction Potency Model
- (2015) Bhagwan Yadav et al. Computational and Structural Biotechnology Journal
- A case of iatrogenic adrenal suppression after co-administration of cobicistat and fluticasone nasal drops
- (2014) Joe Lewis et al. AIDS
- Bioequivalence of a darunavir/cobicistat fixed-dose combination tablet versus single agents and food effect in healthy volunteers
- (2014) Thomas N Kakuda et al. ANTIVIRAL THERAPY
- Cobicistat: A Review of Its Use as a Pharmacokinetic Enhancer of Atazanavir and Darunavir in Patients with HIV-1 Infection
- (2013) Emma D. Deeks DRUGS
- PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data
- (2013) Daniel R. Roe et al. Journal of Chemical Theory and Computation
- The P-Glycoprotein Transport System and Cardiovascular Drugs
- (2013) Jeffrey D. Wessler et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cobicistat Boosts the Intestinal Absorption of Transport Substrates, Including HIV Protease Inhibitors and GS-7340,In Vitro
- (2012) Eve-Irene Lepist et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- MMPBSA.py: An Efficient Program for End-State Free Energy Calculations
- (2012) Bill R. Miller et al. Journal of Chemical Theory and Computation
- Classification Models for Predicting Cytochrome P450 Enzyme-Substrate Selectivity
- (2012) Tao Zhang et al. Molecular Informatics
- Fiji: an open-source platform for biological-image analysis
- (2012) Johannes Schindelin et al. NATURE METHODS
- CYP isoform specificity toward drug metabolism: analysis using common feature hypothesis
- (2011) M. Ramesh et al. JOURNAL OF MOLECULAR MODELING
- Effects of cytochrome P450 3A (CYP3A) and the drug transporters P-glycoprotein (MDR1/ABCB1) and MRP2 (ABCC2) on the pharmacokinetics of lopinavir
- (2010) RAB van Waterschoot et al. BRITISH JOURNAL OF PHARMACOLOGY
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- Drug-drug interactions in the treatment of HIV infection: focus on pharmacokinetic enhancement through CYP3A inhibition
- (2010) F. Josephson JOURNAL OF INTERNAL MEDICINE
- Prediction of cytochrome P450 isoform responsible for metabolizing a drug molecule
- (2010) Nitish K Mishra et al. BMC Pharmacology & Toxicology
- Pharmacokinetics and Pharmacodynamics of GS-9350: A Novel Pharmacokinetic Enhancer Without Anti-HIV Activity
- (2009) A A Mathias et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Comparison of Multilabel and Single-Label Classification Applied to the Prediction of the Isoform Specificity of Cytochrome P450 Substrates
- (2009) Lisa Michielan et al. Journal of Chemical Information and Modeling
- Novel Hierarchical Classification and Visualization Method for Multiobjective Optimization of Drug Properties: Application to Structure−Activity Relationship Analysis of Cytochrome P450 Metabolism
- (2008) Fumiyoshi Yamashita et al. Journal of Chemical Information and Modeling
- Entry from the Cell Surface of Severe Acute Respiratory Syndrome Coronavirus with Cleaved S Protein as Revealed by Pseudotype Virus Bearing Cleaved S Protein
- (2008) R. Watanabe et al. JOURNAL OF VIROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now